Sasson Y - Search Results

1

Brain reactivity to specific symptom provocation indicates prospective therapeutic outcome in OCD.

Hendler T, Goshen E, Tzila Zwas S, Sasson Y, Gal G, Zohar J. Hendler T, et al. Among authors: sasson y. Psychiatry Res. 2003 Oct 30;124(2):87-103. doi: 10.1016/s0925-4927(03)00091-x. Psychiatry Res. 2003. PMID: 14561427

2

Posttraumatic obsessive-compulsive disorder: a case series.

Sasson Y, Dekel S, Nacasch N, Chopra M, Zinger Y, Amital D, Zohar J. Sasson Y, et al. Psychiatry Res. 2005 Jun 15;135(2):145-52. doi: 10.1016/j.psychres.2004.05.026. Psychiatry Res. 2005. PMID: 15922457

3

Serotonergic dissection of obsessive compulsive symptoms: a challenge study with m-chlorophenylpiperazine and sumatriptan.

Gross-Isseroff R, Cohen R, Sasson Y, Voet H, Zohar J. Gross-Isseroff R, et al. Among authors: sasson y. Neuropsychobiology. 2004;50(3):200-5. doi: 10.1159/000079970. Neuropsychobiology. 2004. PMID: 15365215 Clinical Trial.

4

Relationship between childhood sexual abuse and obsessive-compulsive disorder: case control study.

Caspi A, Vishne T, Sasson Y, Gross R, Livne A, Zohar J. Caspi A, et al. Among authors: sasson y. Isr J Psychiatry Relat Sci. 2008;45(3):177-82. Isr J Psychiatry Relat Sci. 2008. PMID: 19398821 Free article.

5

Olfactory sensitivity in major depressive disorder and obsessive compulsive disorder.

Gross-Isseroff R, Luca-Haimovici K, Sasson Y, Kindler S, Kotler M, Zohar J. Gross-Isseroff R, et al. Among authors: sasson y. Biol Psychiatry. 1994 May 15;35(10):798-802. doi: 10.1016/0006-3223(94)91142-8. Biol Psychiatry. 1994. PMID: 8043710

6

Alternation learning in obsessive-compulsive disorder.

Gross-Isseroff R, Sasson Y, Voet H, Hendler T, Luca-Haimovici K, Kandel-Sussman H, Zohar J. Gross-Isseroff R, et al. Among authors: sasson y. Biol Psychiatry. 1996 Apr 15;39(8):733-8. doi: 10.1016/0006-3223(95)00179-4. Biol Psychiatry. 1996. PMID: 8731461 Clinical Trial.

7

The pathogenesis and treatment of obsessive-compulsive disorder.

Dolberg OT, Iancu I, Sasson Y, Zohar J. Dolberg OT, et al. Among authors: sasson y. Clin Neuropharmacol. 1996 Apr;19(2):129-47. doi: 10.1097/00002826-199619020-00002. Clin Neuropharmacol. 1996. PMID: 8777767 Review.

8

New developments in obsessive-compulsive disorder research: implications for clinical management.

Sasson Y, Zohar J. Sasson Y, et al. Int Clin Psychopharmacol. 1996 Dec;11 Suppl 5:3-12. doi: 10.1097/00004850-199612005-00002. Int Clin Psychopharmacol. 1996. PMID: 9031999 Review.

9

Epidemiology of obsessive-compulsive disorder: a world view.

Sasson Y, Zohar J, Chopra M, Lustig M, Iancu I, Hendler T. Sasson Y, et al. J Clin Psychiatry. 1997;58 Suppl 12:7-10. J Clin Psychiatry. 1997. PMID: 9393390 Review.

10

Treatment of severe, drug resistant obsessive compulsive disorder with the 5HT1D agonist sumatriptan.

Stern L, Zohar J, Cohen R, Sasson Y. Stern L, et al. Among authors: sasson y. Eur Neuropsychopharmacol. 1998 Dec;8(4):325-8. doi: 10.1016/s0924-977x(97)00092-8. Eur Neuropsychopharmacol. 1998. PMID: 9928925

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

68 results

Search Page

Filters